P/E ratio for Neogen (NEOG)

P/E ratio history for Neogen from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
PerkinElmer PKI	15.0	-114.49%	🇺🇸 USA
IDEXX Laboratories IDXX	41.6	-140.33%	🇺🇸 USA
Illumina ILMN	-5.02	-95.14%	🇺🇸 USA
Pacific Biosciences PACB	-1.41	-98.64%	🇺🇸 USA
Meridian Bioscience VIVO	35.0	-133.91%	🇺🇸 USA
Thermo Fisher Scientific TMO	33.8	-132.75%	🇺🇸 USA
Danaher DHR	28.6	-127.73%	🇺🇸 USA
Becton Dickinson BDX	40.8	-139.52%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.